Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-18 Purchase | 2025-12-22 11:43 am | Kyverna Therapeutics Inc. | KYTX | SEIDENBERG BETH C Director | 133,333 | $7.5 | $999,998 | 4,673,891 (Indirect Direct) | View |
| 2025-12-18 Purchase | 2025-12-22 11:42 am | Kyverna Therapeutics Inc. | KYTX | Westlake BioPartners Opportunity Fund I L.P. Westlake BioPartners Opportunity GP I LLC Westlake BioPartners Fund I L.P. Westlake BioPartners GP I LLC 10% Owner | 133,333 | $7.5 | $999,998 | 4,657,257 (Indirect) | View |
| 2025-12-15 Sale | 2025-12-17 8:30 pm | Kyverna Therapeutics Inc. | KYTX | Walker Karen Marie Chief Technology Officer | 23,998 | $12.2 | $292,776 | 108,501 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-27 Option Award | 2026-05-29 4:30 pm | N/A 2036-05-27 | Kyverna Therapeutics Inc. | KYTX | CLARK IAN T Director | 25,675 | $0 | 42,309 (Direct) | View |
| 2026-05-27 Option Award | 2026-05-29 4:30 pm | N/A 2036-05-27 | Kyverna Therapeutics Inc. | KYTX | Cohen Fred E Director | 25,675 | $0 | 4,566,233 (Direct) | View |
| 2026-05-27 Option Award | 2026-05-29 4:30 pm | N/A 2036-05-27 | Kyverna Therapeutics Inc. | KYTX | SEIDENBERG BETH C Director | 25,675 | $0 | 4,699,566 (Direct) | View |
| 2026-05-27 Tax Withholding | 2026-05-29 4:30 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Shaw Christi Executive Chairperson | 4,194 | $8.59 | 66,741 (Direct) | View |
| 2026-05-27 Option Award | 2026-05-29 4:30 pm | N/A 2036-05-27 | Kyverna Therapeutics Inc. | KYTX | Aktar Mert Director | 25,675 | $0 | 42,309 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:30 pm | N/A 2036-05-18 | Kyverna Therapeutics Inc. | KYTX | Martini Gregory S. Chief Financial Officer | 325,000 | $0 | 325,000 (Direct) | View |
| 2026-05-04 Option Award | 2026-05-06 4:30 pm | N/A 2036-05-04 | Kyverna Therapeutics Inc. | KYTX | Dac Nadia Chief Commercial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2026-03-13 Option Award | 2026-03-17 4:30 pm | N/A 2036-03-13 | Kyverna Therapeutics Inc. | KYTX | GRASSO MARC Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2026-03-13 Option Award | 2026-03-17 4:30 pm | N/A 2036-03-13 | Kyverna Therapeutics Inc. | KYTX | Biddle Warner Weston Chief Executive Officer | 408,000 | $0 | 408,000 (Direct) | View |
| 2026-03-13 Option Award | 2026-03-17 4:30 pm | N/A 2036-03-13 | Kyverna Therapeutics Inc. | KYTX | GEHCHAN NAJI See Remarks | 123,000 | $0 | 123,000 (Direct) | View |
| 2026-02-24 Option Award | 2026-03-04 4:30 pm | N/A 2036-02-24 | Kyverna Therapeutics Inc. | KYTX | Miller Andrew Craig Director | 53,951 | $0 | 53,951 (Direct) | View |
| 2026-02-24 Option Award | 2026-02-26 4:30 pm | N/A 2036-02-24 | Kyverna Therapeutics Inc. | KYTX | Emany Sravan Kumar Director | 53,951 | $0 | 53,951 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 4:30 pm | N/A 2036-02-09 | Kyverna Therapeutics Inc. | KYTX | Pujols Mayobanex Chief Technology Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 5:00 pm | N/A 2036-01-11 | Kyverna Therapeutics Inc. | KYTX | Shaw Christi Executive Chairperson | 239,301 | $0 | 255,935 (Direct) | View |
| 2025-12-15 Exercise | 2025-12-17 8:30 pm | N/A 2033-11-05 | Kyverna Therapeutics Inc. | KYTX | Walker Karen Marie Chief Technology Officer | 23,998 | $0 | 108,501 (Direct) | View |
| 2025-12-15 Exercise | 2025-12-17 8:30 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Walker Karen Marie Chief Technology Officer | 23,998 | $4.83 | 108,501 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-01 8:28 pm | N/A 2035-06-30 | Kyverna Therapeutics Inc. | KYTX | GRASSO MARC Chief Financial Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:40 pm | N/A 2035-05-29 | Kyverna Therapeutics Inc. | KYTX | Shaw Christi Director | 81,985 | $0 | 81,985 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:35 pm | N/A 2035-05-29 | Kyverna Therapeutics Inc. | KYTX | SEIDENBERG BETH C Director 10% Owner | 81,985 | $0 | 4,605,909 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:35 pm | N/A 2035-05-29 | Kyverna Therapeutics Inc. | KYTX | SPIEGELMAN DANIEL K Director | 81,985 | $0 | 81,985 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:32 pm | N/A 2035-05-29 | Kyverna Therapeutics Inc. | KYTX | Aktar Mert Director | 81,985 | $0 | 81,985 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:32 pm | N/A 2035-05-29 | Kyverna Therapeutics Inc. | KYTX | CLARK IAN T Director | 81,985 | $0 | 81,985 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:30 pm | N/A 2035-05-29 | Kyverna Therapeutics Inc. | KYTX | Cohen Fred E Director 10% Owner | 81,985 | $0 | 4,605,909 (Direct) | View |
| 2024-04-11 Option Award | 2025-04-15 5:42 pm | N/A 2035-04-11 | Kyverna Therapeutics Inc. | KYTX | Biddle Warner Weston Chief Executive Officer | 332,500 | $0 | 332,500 (Direct) | View |
| 2024-04-11 Option Award | 2025-04-15 5:42 pm | N/A 2035-04-11 | Kyverna Therapeutics Inc. | KYTX | Jones Ryan Alexander Chief Financial Officer | 86,000 | $0 | 129,950 (Direct) | View |
| 2024-04-11 Option Award | 2025-04-15 5:40 pm | N/A 2035-04-11 | Kyverna Therapeutics Inc. | KYTX | Walker Karen Marie Chief Technology Officer | 93,000 | $0 | 102,636 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 5:55 pm | N/A 2035-02-14 | Kyverna Therapeutics Inc. | KYTX | Shaw Christi Director | 38,679 | $0 | 38,679 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 8:05 pm | N/A 2035-01-22 | Kyverna Therapeutics Inc. | KYTX | GEHCHAN NAJI See Remarks | 425,000 | $0 | 425,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-24 06:05 am | N/A 2034-10-21 | Kyverna Therapeutics Inc. | KYTX | Aktar Mert Director | 87,741 | $0 | 87,741 (Direct) | View |
| 2024-09-16 Option Award | 2024-09-18 9:18 pm | N/A 2034-09-16 | Kyverna Therapeutics Inc. | KYTX | Biddle Warner Weston Chief Executive Officer | 2,579,259 | $0 | 2,579,259 (Direct) | View |
| 2024-09-16 Option Award | 2024-09-18 9:16 pm | N/A 2034-09-16 | Kyverna Therapeutics Inc. | KYTX | Shaw Christi Director | 66,592 | $0 | 66,592 (Direct) | View |